Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-061190
Filing Date
2025-06-20
Accepted
2025-06-20 16:31:54
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518541-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2518541-4_4seq1.xml 4 4245
  Complete submission text file 0001104659-25-061190.txt   5710
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 C/O ARALEZ PHARMACEUTICALS INC. MISSISSAUGA A6 L5N 0E4
Business Address
Kirsch Arthur S (Reporting) CIK: 0001290976 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39724 | Film No.: 251061891

Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Issuer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)